Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$40.85 - $77.67 $739,344 - $1.41 Million
18,099 Added 723.67%
20,600 $903,000
Q1 2022

May 16, 2022

SELL
$59.95 - $92.06 $824,672 - $1.27 Million
-13,756 Reduced 84.62%
2,501 $181,000
Q4 2021

Feb 14, 2022

BUY
$81.07 - $121.29 $607,619 - $909,068
7,495 Added 85.54%
16,257 $1.32 Million
Q3 2021

Nov 15, 2021

BUY
$101.99 - $166.36 $893,636 - $1.46 Million
8,762 New
8,762 $1.02 Million
Q4 2020

Feb 16, 2021

SELL
$138.17 - $184.34 $1.37 Million - $1.83 Million
-9,904 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$114.09 - $145.51 $760,181 - $969,533
6,663 Added 205.58%
9,904 $1.38 Million
Q2 2020

Aug 14, 2020

BUY
$89.45 - $129.85 $3,578 - $5,194
40 Added 1.25%
3,241 $387,000
Q1 2020

May 15, 2020

BUY
$70.23 - $144.31 $224,806 - $461,936
3,201 New
3,201 $320,000
Q4 2018

Feb 14, 2019

SELL
$35.43 - $56.29 $192,349 - $305,598
-5,429 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$44.22 - $75.47 $240,070 - $409,726
5,429 New
5,429 $310,000
Q2 2018

Aug 14, 2018

SELL
$72.38 - $92.5 $184,786 - $236,152
-2,553 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$69.46 - $88.57 $177,331 - $226,119
2,553 New
2,553 $221,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $163M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.